KdT Ventures | Activity | F4

Introducing F4 Champions, a new accelerator for founders at the earliest stage.F4 Champions for early-stage foundersEnrollment closesAugust 2Learn more

Team Portfolio Raise Champions Essays

F4/KdT Ventures/Activity

KdT Ventures Activity

Every public signal F4 has attached to this firm, with sources and cross-entity links.

Types

Time range

Investment

Participated in PHNX Materials' $6.5M seed financing to build domestic critical-materials supply from industrial waste.

PHNX Materials

PHNX Materials KdT Ventures

wsj.comMAY 8, 2026

kdtvc.com

MAY 8, 2026

Investment

Led $5M Series A for Index Biosystems, a food safety and biotech platform company using BioTag technology.

Index Biosystems

Index Biosystems KdT Ventures

indexbiosystems.com

Added recently

Milestone

Portfolio company Montara Therapeutics announced first development candidate for BrainOnly platform.

Montara Therapeutics

Montara Therapeutics KdT Ventures

montaratx.comDEC 8, 2025

DEC 8, 2025

3 exits· JAN 2025 – OCT 2025Show all

Exit

Portfolio company MapLight Therapeutics completed IPO in October 2025.

MapLight Therapeutics

MapLight Therapeutics KdT Ventures

pharmexec.comOCT 26, 2025

OCT 26, 2025

Exit

Portfolio company SeQure DX was acquired by MaxCyte in January 2025.

SeQure DX

SeQure DXKdT Ventures

pitchbook.comJAN 2025

JAN 2025

Exit

Portfolio company Tavros Therapeutics achieved acquisition.

Tavros Therapeutics

Tavros TherapeuticsKdT Ventures

pitchbook.comJAN 2025

JAN 2025